Inventor · disambiguated record
Huiming Li
Also filed as: LI HUIMING
14 granted patents·9 pending applications·141 citations·filing 2015–2025
92Inventor score
Files withBRISTOL MYERS SQUIBB CO23
Top patents by PatentIndex Score
23 records- 0198US9228016B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 5, 2016·85 cites·19 claims
- 0297US10501550B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 10, 2019·9 cites·58 claims
- 0397US10465010B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 5, 2019·9 cites·15 claims
- 0497US9745379B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 29, 2017·11 cites·58 claims
- 0594US12312403B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Granted May 27, 2025·1 cites·17 claims
- 0694US11084881B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 10, 2021·3 cites·19 claims
- 0794US10077306B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 18, 2018·7 cites·22 claims
- 0893US11213586B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 4, 2022·5 cites·14 claims
- 0993US10533052B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 14, 2020·4 cites·30 claims
- 1092US10690674B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·5 cites·27 claims
- 1188US2024158524A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1287US2024209083A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1386US11591392B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 28, 2023·1 cites·19 claims
- 1484US11408889B2Anti-GITR antibodies for cancer diagnosticsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 1579US2023050665A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1678US2024174749A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1777US11802162B2Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 31, 2023·0 cites·25 claims
- 1876US2025326841A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1976US2025115664A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2071US2022175921A1Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2168US2025197494A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 2262US12129297B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 29, 2024·0 cites·10 claims
- 2361US2021363242A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Huiming Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →